-
Author
Ajayi, Oluseyi F 1 Albanesi, Estela I 1 Alejo, Maria 1 Alemany, Laia 1 Alvarado-Cabrero, Isabel 1 Alòs, Llúcia 1 Benevolo, Maria 1 Biegner, Thorsten 1 Bravo, Ignacio G 1 Cadena, Enrique 1 Castellsagué, Xavier 1 Claros, Edith 1 Clavero, Omar 1 Costes, Valérie 1 Dabed, Pablo 1 Duarte, Flora 1 Duran-Padilla, Marco A 1 Ferrera, Annabelle 1 Félix, Ana 1 Garcia-Rojo, Marcial 1
-
Workplace
CIBER Epidemiología y Salud Pública 1 Cancer Epidemiology Research Program Catalan... 1 DDL Diagnostic Laboratory Rijswijk the Nethe... 1 Department of Otorhinolaryngology Faculty of... 1 Department of Pathology University Hospital ... 1 Department of Social and Preventive Medicine... 1 German Cancer Research Center 1 Hospital Clínic University of Barcelona Spain 1 Hospital General de l'Hospitalet L'Hospitale... 1 Hospital Sant Pau Barcelona Spain 1 Hospital de Oncología Centro Médico Nacional... 1 Insituto Oncológico del Oriente Boliviano 1 Institute of Head and Neck Studies and Educa... 1 Instituto Nacional de Cancerología Bogotá Co... 1 Instituto de Investigaciones en Ciencias de ... 1 Laboratorio Clínico y Molecular Hospital SOL... 1 Manchester Royal Infirmary Manchester UK 1 Pathology Department Hospital del Mar IMIM U... 1 Regina Elena National Cancer Institute Rome ... 1 The Fingerland Department of Pathology Charl... 1
- Format
- Publication type
- Check Tag
- Category
- Language
- Country
- Journal/source
- Accessibility
- Owner
-
Castellsagué, Xavier
Author Castellsagué, Xavier Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Alemany, Laia
Author Alemany, Laia Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Quer, Miquel
Author Quer, Miquel Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Halec, Gordana
Author Halec, Gordana Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Quirós, Beatriz
Author Quirós, Beatriz Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Tous, Sara
Author Tous, Sara Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Clavero, Omar
Author Clavero, Omar Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Alòs, Llúcia
Author Alòs, Llúcia Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Biegner, Thorsten
Author Biegner, Thorsten Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
-
Szafarowski, Tomasz
Author Szafarowski, Tomasz Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Spain (XC, LAle, BQ, ST, OC, MM, IGB, SdS, FXB) CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain (XC, LAle, SdS) Hospital Sant Pau, Barcelona, Spain (MQ, XL) German Cancer Research Center (DKFZ), Heidelberg, Germany (GHale, DH, MPa) Hospital Clínic, University of Barcelona, Spain (LAlò) Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany (TB) Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Warsaw Medical University, Czerniakowski Hospital, Warsaw, Poland (TS) Hospital General de l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain (MA) Instituto Nacional de Cancerología, Bogotá, Colombia (ECa, NM) Universidad Nacional de Colombia, Bogotá, Colombia (ECa) Insituto Oncológico del Oriente Boliviano (IOOB), Laboratorio Privado de Patología Oncos, Santa Cruz, Bolivia (ECl) Manchester Royal Infirmary, Manchester, UK (GHall) The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic (JL) University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia (MPo) Regina Elena National Cancer Institute, Rome, Italy (MB) Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Asunción, Paraguay (EK) Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK (HMe) Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada (CN) DDL Diagnostic Laboratory, Rijswijk, the Netherlands (NG, WQ) Pathology Department, Hospital del Mar IMIM, Universitat Pompeu Fabra, Barcelona, Spain (BL) Laboratorio Clínico y Molecular, Hospital SOLCA, Guayaquil, Ecuador (JCRC) Hospital de Oncología Centro Médico Nacional Siglo XXI, IMSS Mexico, D.F., Mexico (IAC) Yeouido St. Mary's
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
PubMed
26823521
DOI
10.1093/jnci/djv403
Knihovny.cz E-resources
BACKGROUND: We conducted a large international study to estimate fractions of head and neck cancers (HNCs) attributable to human papillomavirus (HPV-AFs) using six HPV-related biomarkers of viral detection, transcription, and cellular transformation. METHODS: Formalin-fixed, paraffin-embedded cancer tissues of the oral cavity (OC), pharynx, and larynx were collected from pathology archives in 29 countries. All samples were subject to histopathological evaluation, DNA quality control, and HPV-DNA detection. Samples containing HPV-DNA were further subject to HPV E6*I mRNA detection and to p16(INK4a), pRb, p53, and Cyclin D1 immunohistochemistry. Final estimates of HPV-AFs were based on HPV-DNA, HPV E6*I mRNA, and/or p16(INK4a) results. RESULTS: A total of 3680 samples yielded valid results: 1374 pharyngeal, 1264 OC, and 1042 laryngeal cancers. HPV-AF estimates based on positivity for HPV-DNA, and for either HPV E6*I mRNA or p16(INK4a), were 22.4%, 4.4%, and 3.5% for cancers of the oropharynx, OC, and larynx, respectively, and 18.5%, 3.0%, and 1.5% when requiring simultaneous positivity for all three markers. HPV16 was largely the most common type. Estimates of HPV-AF in the oropharynx were highest in South America, Central and Eastern Europe, and Northern Europe, and lowest in Southern Europe. Women showed higher HPV-AFs than men for cancers of the oropharynx in Europe and for the larynx in Central-South America. CONCLUSIONS: HPV contribution to HNCs is substantial but highly heterogeneous by cancer site, region, and sex. This study, the largest exploring HPV attribution in HNCs, confirms the important role of HPVs in oropharyngeal cancer and drastically downplays the previously reported involvement of HPVs in the other HNCs.
- MeSH
- Cyclin D1 analysis MeSH
- DNA, Viral isolation & purification MeSH
- Adult MeSH
- Genotype MeSH
- Immunohistochemistry MeSH
- Papillomavirus Infections complications virology MeSH
- Cyclin-Dependent Kinase Inhibitor p16 analysis MeSH
- Middle Aged MeSH
- Humans MeSH
- Human papillomavirus 16 isolation & purification MeSH
- International Cooperation MeSH
- Biomarkers, Tumor analysis MeSH
- Tumor Suppressor Protein p53 analysis MeSH
- Head and Neck Neoplasms virology MeSH
- Oropharyngeal Neoplasms chemistry virology MeSH
- Papillomaviridae genetics isolation & purification MeSH
- Predictive Value of Tests MeSH
- Cross-Sectional Studies MeSH
- Aged MeSH
- Salivary Proline-Rich Proteins analysis MeSH
- Carcinoma, Squamous Cell chemistry virology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
Refine by MeSH
Share
Document title
The link will be redirected to the address of the production version after the testing phase.